Skip to main content
CriticalFDAfda-F-0245-2025UNDECLARED ALLERGEN

Wegmans Large Asian Sesame Salad with Chicken and Asian Peanut Dressing.

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Units Affected
365
Recall Date
November 8, 2024
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0245-2025.

Contains undeclared egg

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0245-2025.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Wegmans Food Markets, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0245-2025.

Wegmans Food Markets, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Wegmans Food Markets, Inc. Recall FAQ

Wegmans Food Markets, Inc. is the subject of a meat & poultry safety report: Wegmans Large Asian Sesame Salad with Chicken and Asian Peanut Dressing.. The notice was published on November 8, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 365 units are potentially affected.